NASBA (molecular biology)

Last updated

Nucleic acid sequence-based amplification, commonly referred to as NASBA, is a method in molecular biology which is used to produce multiple copies of single stranded RNA. [1] NASBA is a two-step process that takes RNA and anneals specially designed primers, then utilizes an enzyme cocktail to amplify it. [2]

Contents

Background

Nucleic acid amplification is a technique used to produce several copies of a specific segment of RNA/DNA. [3] Amplified RNA and DNA can be used for a variety of applications, such as genotyping, sequencing, and detection of bacteria or viruses. [4] There are two different types of amplification, non-isothermal and isothermal. [5] Non-isothermal amplification produces multiple copies of RNA/DNA through reiterative cycling between different temperatures. [6] Isothermal amplification produces multiple copies of RNA/DNA at a constant reaction temperature. [7] NASBA takes single stranded RNA, anneals primers to it at 65°C, and then amplifies it at 41°C to produce multiple copies of single stranded RNA. [8] In order for successful amplification to occur, an enzyme cocktail containing, Avian Myeloblastosis Reverse Transcriptase (AMV-RT), RNase H, and RNA polymerase is used. [9] AMV-RT synthesizes a complementary DNA strand (cDNA) from the RNA template once the primer is annealed. [10] RNase H then degrades the RNA template and the other primer binds to the cDNA to form double stranded DNA, which RNA polymerase uses to synthesize copies of RNA. [11] One key aspect of NASBA is that the starting material and end product is always single stranded RNA. That being said, it can be used to amplify DNA, but the DNA must be translated into RNA in order for successful amplification to occur.

Loop-mediated isothermal amplification (LAMP) is another isothermal amplification technique.

History

NASBA was developed by J Compton in 1991, who defined it as "a primer-dependent technology that can be used for the continuous amplification of nucleic acids in a single mixture at one temperature". [12] Immediately after the invention of NASBA it was used for the rapid diagnosis and quantification of HIV-1 in patient sera. [13] Although RNA can also be amplified by PCR using a reverse transcriptase (in order to synthesize a complementary DNA strand as a template), NASBA's main advantage is that it works under isothermal conditions – usually at a constant temperature of 41 °C or two different temperatures, depending on the primers and enzymes used. Even when two different temperatures are applied, it is still considered isothermal, because it does not cycle back and forth between those temperatures. NASBA can be used in medical diagnostics as an alternative to PCR that is quicker and more sensitive in some circumstances. [14]

Procedure

Explained briefly, NASBA works as follows:

  1. RNA template added to the reaction mixture, the first primer with the T7 promoter region on its 5' end attaches to its complementary site at the 3' end of the template.
  2. Reverse transcriptase synthesizes the opposite complementary DNA strand extending the 3' end of the primer, moving upstream along the RNA template.
  3. RNAse H destroys the RNA template from the DNA-RNA compound (RNAse H only destroys RNA in RNA-DNA hybrids, but not single-stranded RNA).
  4. The second primer attaches to the 5' end of the (antisense) DNA strand.
  5. Reverse transcriptase again synthesizes another DNA strand from the attached primer resulting in double stranded DNA.
  6. T7 RNA polymerase binds to the promoter region on the double strand. Since T7 RNA polymerase can only transcribe in the 3' to 5' direction [15] the sense DNA is transcribed and an anti-sense RNA is produced. This is repeated, and the polymerase continuously produces complementary RNA strands of this template which results in amplification.
  7. Now a cyclic phase can begin similar to the previous steps. Here, however, the second primer first binds to the (-)RNA
  8. The reverse transcriptase now produces a (+)cDNA/(-)RNA duplex.
  9. RNAse H again degrades the RNA and the first primer binds to the now single stranded +(cDNA)
  10. The reverse transcriptase now produces the complementary (-)DNA, creating a dsDNA duplex
  11. Exactly like step 6, the T7 polymerase binds to the promoter region to produce (-)RNA, and the cycle is complete.

Clinical applications

The NASBA technique has been used to develop rapid diagnostic tests for several pathogenic viruses with single-stranded RNA genomes, e.g. influenza A, [16] zika virus, foot-and-mouth disease virus, [17] severe acute respiratory syndrome (SARS)-associated coronavirus, [18] human bocavirus (HBoV) [19] and also parasites like Trypanosoma brucei . [20]

Recently, NASBA reaction with fluoresce, dipstick and next generation sequencing readout has been developed for COVID-19 diagnosis. [21]

See also

Related Research Articles

<span class="mw-page-title-main">Complementary DNA</span> DNA reverse transcribed from RNA

In genetics, complementary DNA (cDNA) is DNA that was reverse transcribed from an RNA. cDNA exists in both single-stranded and double-stranded forms and in both natural and engineered forms.

<span class="mw-page-title-main">Polymerase chain reaction</span> Laboratory technique to multiply a DNA sample for study

The polymerase chain reaction (PCR) is a method widely used to make millions to billions of copies of a specific DNA sample rapidly, allowing scientists to amplify a very small sample of DNA sufficiently to enable detailed study. PCR was invented in 1983 by American biochemist Kary Mullis at Cetus Corporation. Mullis and biochemist Michael Smith, who had developed other essential ways of manipulating DNA, were jointly awarded the Nobel Prize in Chemistry in 1993.

<span class="mw-page-title-main">Primer (molecular biology)</span> Short strand of RNA or DNA that serves as a starting point for DNA synthesis

A primer is a short, single-stranded nucleic acid used by all living organisms in the initiation of DNA synthesis. A synthetic primer may also be referred to as an oligo, short for oligonucleotide. DNA polymerase enzymes are only capable of adding nucleotides to the 3’-end of an existing nucleic acid, requiring a primer be bound to the template before DNA polymerase can begin a complementary strand. DNA polymerase adds nucleotides after binding to the RNA primer and synthesizes the whole strand. Later, the RNA strands must be removed accurately and replace them with DNA nucleotides forming a gap region known as a nick that is filled in using an enzyme called ligase. The removal process of the RNA primer requires several enzymes, such as Fen1, Lig1, and others that work in coordination with DNA polymerase, to ensure the removal of the RNA nucleotides and the addition of DNA nucleotides. Living organisms use solely RNA primers, while laboratory techniques in biochemistry and molecular biology that require in vitro DNA synthesis usually use DNA primers, since they are more temperature stable. Primers can be designed in laboratory for specific reactions such as polymerase chain reaction (PCR). When designing PCR primers, there are specific measures that must be taken into consideration, like the melting temperature of the primers and the annealing temperature of the reaction itself. Moreover, the DNA binding sequence of the primer in vitro has to be specifically chosen, which is done using a method called basic local alignment search tool (BLAST) that scans the DNA and finds specific and unique regions for the primer to bind.

<span class="mw-page-title-main">Retrovirus</span> Family of viruses

A retrovirus is a type of virus that inserts a DNA copy of its RNA genome into the DNA of a host cell that it invades, thus changing the genome of that cell. After invading a host cell's cytoplasm, the virus uses its own reverse transcriptase enzyme to produce DNA from its RNA genome, the reverse of the usual pattern, thus retro (backward). The new DNA is then incorporated into the host cell genome by an integrase enzyme, at which point the retroviral DNA is referred to as a provirus. The host cell then treats the viral DNA as part of its own genome, transcribing and translating the viral genes along with the cell's own genes, producing the proteins required to assemble new copies of the virus. Many retroviruses cause serious diseases in humans, other mammals, and birds.

<span class="mw-page-title-main">Reverse transcriptase</span> Enzyme which generates DNA

A reverse transcriptase (RT) is an enzyme used to convert RNA genome to DNA, a process termed reverse transcription. Reverse transcriptases are used by viruses such as HIV and hepatitis B to replicate their genomes, by retrotransposon mobile genetic elements to proliferate within the host genome, and by eukaryotic cells to extend the telomeres at the ends of their linear chromosomes. Contrary to a widely held belief, the process does not violate the flows of genetic information as described by the classical central dogma, as transfers of information from RNA to DNA are explicitly held possible.

Viral load, also known as viral burden, is a numerical expression of the quantity of virus in a given volume of fluid, including biological and environmental specimens. It is not to be confused with viral titre or viral titer, which depends on the assay. When an assay for measuring the infective virus particle is done, viral titre often refers to the concentration of infectious viral particles, which is different from the total viral particles. Viral load is measured using body fluids sputum and blood plasma. As an example of environmental specimens, the viral load of norovirus can be determined from run-off water on garden produce. Norovirus has not only prolonged viral shedding and has the ability to survive in the environment but a minuscule infectious dose is required to produce infection in humans: less than 100 viral particles.

DNA primase is an enzyme involved in the replication of DNA and is a type of RNA polymerase. Primase catalyzes the synthesis of a short RNA segment called a primer complementary to a ssDNA template. After this elongation, the RNA piece is removed by a 5' to 3' exonuclease and refilled with DNA.

<span class="mw-page-title-main">Ribonuclease H</span> Enzyme family

Ribonuclease H is a family of non-sequence-specific endonuclease enzymes that catalyze the cleavage of RNA in an RNA/DNA substrate via a hydrolytic mechanism. Members of the RNase H family can be found in nearly all organisms, from bacteria to archaea to eukaryotes.

<span class="mw-page-title-main">Real-time polymerase chain reaction</span> Laboratory technique of molecular biology

A real-time polymerase chain reaction is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR). It monitors the amplification of a targeted DNA molecule during the PCR, not at its end, as in conventional PCR. Real-time PCR can be used quantitatively and semi-quantitatively.

<span class="mw-page-title-main">Rolling circle replication</span> DNA synthesis technique

Rolling circle replication (RCR) is a process of unidirectional nucleic acid replication that can rapidly synthesize multiple copies of circular molecules of DNA or RNA, such as plasmids, the genomes of bacteriophages, and the circular RNA genome of viroids. Some eukaryotic viruses also replicate their DNA or RNA via the rolling circle mechanism.

In molecular biology and genetics, the sense of a nucleic acid molecule, particularly of a strand of DNA or RNA, refers to the nature of the roles of the strand and its complement in specifying a sequence of amino acids. Depending on the context, sense may have slightly different meanings. For example, the negative-sense strand of DNA is equivalent to the template strand, whereas the positive-sense strand is the non-template strand whose nucleotide sequence is equivalent to the sequence of the mRNA transcript.

<span class="mw-page-title-main">Multicopy single-stranded DNA</span>

Multicopy single-stranded DNA (msDNA) is a type of extrachromosomal satellite DNA that consists of a single-stranded DNA molecule covalently linked via a 2'-5'phosphodiester bond to an internal guanosine of an RNA molecule. The resultant DNA/RNA chimera possesses two stem-loops joined by a branch similar to the branches found in RNA splicing intermediates. The coding region for msDNA, called a "retron", also encodes a type of reverse transcriptase, which is essential for msDNA synthesis.

Loop-mediated isothermal amplification (LAMP) is a single-tube technique for the amplification of DNA for diagnostic purposes and a low-cost alternative to detect certain diseases. LAMP is an isothermal nucleic acid amplification technique. In contrast to the polymerase chain reaction (PCR) technology, in which the reaction is carried out with a series of alternating temperature steps or cycles, isothermal amplification is carried out at a constant temperature, and does not require a thermal cycler. LAMP was invented in 1998 by Eiken Chemical Company in Tokyo. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) combines LAMP with a reverse transcription step to allow the detection of RNA.

<span class="mw-page-title-main">Nucleic acid test</span> Group of techniques to detect a particular nucleic acid sequence

A nucleic acid test (NAT) is a technique used to detect a particular nucleic acid sequence and thus usually to detect and identify a particular species or subspecies of organism, often a virus or bacterium that acts as a pathogen in blood, tissue, urine, etc. NATs differ from other tests in that they detect genetic materials rather than antigens or antibodies. Detection of genetic materials allows an early diagnosis of a disease because the detection of antigens and/or antibodies requires time for them to start appearing in the bloodstream. Since the amount of a certain genetic material is usually very small, many NATs include a step that amplifies the genetic material—that is, makes many copies of it. Such NATs are called nucleic acid amplification tests (NAATs). There are several ways of amplification, including polymerase chain reaction (PCR), strand displacement assay (SDA), transcription mediated assay (TMA), and loop-mediated isothermal amplification (LAMP).

The versatility of polymerase chain reaction (PCR) has led to modifications of the basic protocol being used in a large number of variant techniques designed for various purposes. This article summarizes many of the most common variations currently or formerly used in molecular biology laboratories; familiarity with the fundamental premise by which PCR works and corresponding terms and concepts is necessary for understanding these variant techniques.

<span class="mw-page-title-main">T7 DNA polymerase</span> Enzyme

T7 DNA polymerase is an enzyme used during the DNA replication of the T7 bacteriophage. During this process, the DNA polymerase “reads” existing DNA strands and creates two new strands that match the existing ones. The T7 DNA polymerase requires a host factor, E. coli thioredoxin, in order to carry out its function. This helps stabilize the binding of the necessary protein to the primer-template to improve processivity by more than 100-fold, which is a feature unique to this enzyme. It is a member of the Family A DNA polymerases, which include E. coli DNA polymerase I and Taq DNA polymerase.

<span class="mw-page-title-main">Hepatitis B virus DNA polymerase</span>

Hepatitis B virus DNA polymerase is a hepatitis B viral protein. It is a DNA polymerase that can use either DNA or RNA templates and a ribonuclease H that cuts RNA in the duplex. Both functions are supplied by the reverse transcriptase (RT) domain.

<span class="mw-page-title-main">Retroviral ribonuclease H</span>

The retroviral ribonuclease H is a catalytic domain of the retroviral reverse transcriptase (RT) enzyme. The RT enzyme is used to generate complementary DNA (cDNA) from the retroviral RNA genome. This process is called reverse transcription. To complete this complex process, the retroviral RT enzymes need to adopt a multifunctional nature. They therefore possess 3 of the following biochemical activities: RNA-dependent DNA polymerase, ribonuclease H, and DNA-dependent DNA polymerase activities. Like all RNase H enzymes, the retroviral RNase H domain cleaves DNA/RNA duplexes and will not degrade DNA or unhybridized RNA.

Recombinase polymerase amplification (RPA) is a single tube, isothermal alternative to the polymerase chain reaction (PCR). By adding a reverse transcriptase enzyme to an RPA reaction, it can detect RNA as well as DNA, without the need for a separate step to produce cDNA. Because it is isothermal, RPA can use much simpler equipment than PCR, which requires a thermal cycler. Operating best at temperatures of 37–42 °C and still working, albeit more slowly, at room temperature means RPA reactions can in theory be run quickly by simply holding a tube in the hand. This makes RPA an excellent candidate for developing low-cost, rapid, point-of-care molecular tests. An international quality assessment of molecular detection of Rift Valley fever virus performed as well as the best RT-PCR tests, detecting less concentrated samples missed by some PCR tests and an RT-LAMP test. RPA was developed and launched by TwistDx Ltd., a biotechnology company based in Cambridge, UK.

<span class="mw-page-title-main">Reverse Transcription Loop-mediated Isothermal Amplification</span>

Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is a one step nucleic acid amplification method to multiply specific sequences of RNA. It is used to diagnose infectious disease caused by RNA viruses.

References

  1. ↑ Deiman, Birgit; van Aarle, Pierre; Sillekens, Peter (2002). "Characteristics and Applications of Nucleic Acid Sequence-Based Amplification (NASBA)". Molecular Biotechnology. 20 (2): 163–180. doi:10.1385/mb:20:2:163. ISSN   1073-6085. PMID   11876473. S2CID   28712952.
  2. ↑ Reed, Adam J.; Connelly, Ryan P.; Williams, Allison; Tran, Maithi; Shim, Byoung-Shik; Choe, Hyeryun; Gerasimova, Yulia V. (March 2019). "Label-free pathogen detection by a deoxyribozyme cascade with visual signal readout". Sensors and Actuators B: Chemical. 282: 945–951. Bibcode:2019SeAcB.282..945R. doi:10.1016/j.snb.2018.11.147. ISSN   0925-4005. PMC   6713451 . PMID   31462856.
  3. ↑ Lamb, Laura E.; Bartolone, Sarah N.; Tree, Maya O.; Conway, Michael J.; Rossignol, Julien; Smith, Christopher P.; Chancellor, Michael B. (December 2018). "Rapid Detection of Zika Virus in Urine Samples and Infected Mosquitos by Reverse Transcription-Loop-Mediated Isothermal Amplification". Scientific Reports. 8 (1): 3803. Bibcode:2018NatSR...8.3803L. doi:10.1038/s41598-018-22102-5. ISSN   2045-2322. PMC   5830622 . PMID   29491389.
  4. ↑ Schachter, Julius (1997), "Evaluation of Diagnostic Tests — Special Problems Introduced by DNA Amplification Procedures", Nucleic Acid Amplification Technologies Application to Disease Diagnosis, Boston, MA: Birkhäuser Boston, pp. 165–169, doi:10.1007/978-1-4612-2454-9_12 (inactive 1 November 2024), ISBN   978-1-4612-7543-5 , retrieved 2020-11-15{{citation}}: CS1 maint: DOI inactive as of November 2024 (link)
  5. ↑ Biolabs, New England. "Isothermal Amplification | NEB". www.neb.com. Retrieved 2020-11-15.
  6. ↑ Biolabs, New England. "Isothermal Amplification | NEB". www.neb.com. Retrieved 2020-11-15.
  7. ↑ Biolabs, New England. "Isothermal Amplification | NEB". www.neb.com. Retrieved 2020-11-15.
  8. ↑ Malek, L.; Sooknanan, R.; Compton, J. (1994). "Nucleic Acid Sequence-Based Amplification (NASBA™)". Protocols for Nucleic Acid Analysis by Nonradioactive Probes. Methods in Molecular Biology. Vol. 28. pp. 253–260. doi:10.1385/0-89603-254-x:253. ISBN   0-89603-254-X. ISSN   1064-3745. PMID   7509695. S2CID   30720773.
  9. ↑ Malek, L.; Sooknanan, R.; Compton, J. (1994). "Nucleic Acid Sequence-Based Amplification (NASBA™)". Protocols for Nucleic Acid Analysis by Nonradioactive Probes. Methods in Molecular Biology. Vol. 28. pp. 253–260. doi:10.1385/0-89603-254-x:253. ISBN   0-89603-254-X. ISSN   1064-3745. PMID   7509695. S2CID   30720773.
  10. ↑ Vasileva Wand, Nadina I.; Bonney, Laura C.; Watson, Robert J.; Graham, Victoria; Hewson, Roger (August 2018). "Point-of-care diagnostic assay for the detection of Zika virus using the recombinase polymerase amplification method". The Journal of General Virology. 99 (8): 1012–1026. doi:10.1099/jgv.0.001083. ISSN   1465-2099. PMC   6171711 . PMID   29897329.
  11. ↑ "PDB101: Molecule of the Month: RNA Polymerase". RCSB: PDB-101. Retrieved 2020-11-15.
  12. ↑ Compton, J (1991). "Nucleic acid sequence-based amplification". Nature. 350 (6313): 91–2. Bibcode:1991Natur.350...91C. doi:10.1038/350091a0. PMID   1706072. S2CID   4304204.
  13. ↑ Kievits, T; Van Gemen, B; Van Strijp, D; Schukkink, R; Dircks, M; Adriaanse, H; Malek, L; Sooknanan, R; Lens, P (1991). "NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection". Journal of Virological Methods. 35 (3): 273–86. doi:10.1016/0166-0934(91)90069-c. PMID   1726172.
  14. ↑ Schneider, P; Wolters, L; Schoone, G; Schallig, H; Sillekens, P; Hermsen, R; Sauerwein, R (2005). "Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of Plasmodium falciparum". Journal of Clinical Microbiology. 43 (1): 402–5. doi:10.1128/JCM.43.1.402-405.2005. PMC   540116 . PMID   15635001.
  15. ↑ Arnaud-Barbe, Nadege; Cheynet Sauvion, Valerie; Oriol, Guy; Mandrand, Bernard; Mallet, Francois (1998). "Transcription of RNA templates by T7 RNA polymerase". Nucleic Acids Research. 26 (15): 3550–3554. doi:10.1093/nar/26.15.3550. PMC   147742 . PMID   9671817.
  16. ↑ Collins, RA; Ko, LS; So, KL; Ellis, T; Lau, LT; Yu, AC (2002). "Detection of highly pathogenic and low pathogenic avian influenza subtype H5 (Eurasian lineage) using NASBA". Journal of Virological Methods. 103 (2): 213–25. doi:10.1016/S0166-0934(02)00034-4. PMID   12008015.
  17. ↑ Collins, RA; Ko, LS; Fung, KY; Lau, LT; Xing, J; Yu, AC (2002). "A method to detect major serotypes of foot-and-mouth disease virus". Biochemical and Biophysical Research Communications. 297 (2): 267–74. CiteSeerX   10.1.1.328.625 . doi:10.1016/S0006-291X(02)02178-2. PMID   12237113.
  18. ↑ Keightley, MC; Sillekens, P; Schippers, W; Rinaldo, C; George, KS (2005). "Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR". Journal of Medical Virology. 77 (4): 602–8. doi: 10.1002/jmv.20498 . PMC   7167117 . PMID   16254971.
  19. ↑ Böhmer, A; Schildgen, V; Lüsebrink, J; Ziegler, S; Tillmann, RL; Kleines, M; Schildgen, O (2009). "Novel application for isothermal nucleic acid sequence-based amplification (NASBA)". Journal of Virological Methods. 158 (1–2): 199–201. doi:10.1016/j.jviromet.2009.02.010. PMID   19428591.
  20. ↑ Mugasa, CM; Laurent, T; Schoone, GJ; Kager, PA; Lubega, GW; Schallig, HD (2009). "Nucleic acid sequence-based amplification with oligochromatography for detection of Trypanosoma brucei in clinical samples". Journal of Clinical Microbiology. 47 (3): 630–5. doi:10.1128/JCM.01430-08. PMC   2650916 . PMID   19116352.
  21. ↑ Wu, Qianxin; Suo, Chenqu; Brown, Tom; Wang, Tengyao; Teichmann, Sarah A.; Bassett, Andrew R. (February 2021). "INSIGHT: A population-scale COVID-19 testing strategy combining point-of-care diagnosis with centralized high-throughput sequencing". Science Advances. 7 (7): eabe5054. Bibcode:2021SciA....7.5054W. doi:10.1126/sciadv.abe5054. ISSN   2375-2548. PMC   7880595 . PMID   33579697.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.